期刊文献+

己酮可可碱对非酒精性脂肪性肝炎大鼠肝NF-κB活性作用的研究 被引量:2

THE EFFECT OF PENTOXIFYLLINE ON HEPATIC NF-κB ACTIVITY OF NONALCOHOLIC STEATOHEPATITIS IN RATS
下载PDF
导出
摘要 目的探讨己酮可可碱(PTX)对非酒精性脂肪性肝炎(NASH)大鼠肝核因子-κB(NF-κB)蛋白的活性作用。方法SD大鼠40只,标准饲料喂养1周后,随机分为4组:对照组、12周模型组、16周模型组和PTX治疗组。用高脂饮食法建立大鼠非酒精性脂肪性肝炎模型,采用免疫组织化学染色法检测大鼠肝组织NF-κB和κB抑制蛋白α(IκB-α)的表达,应用Western blotting的方法检测肝组织中NF-κB的表达。结果免疫组织化学及Westernblotting结果表明,与对照组相比,模型组及PTX治疗组大鼠肝NF-κB的表达显著增加(P<0.05),IκB-α显著降低(P<0.05)。与16周模型组相比,PTX治疗组NF-κB的表达有所降低,IκB-α有显著提高(P<0.05)。结论PTX能抑制大鼠肝IκB的降解,减少NF-κB的活化。 Objective To investigate the effect of pentoxifylline on hepatic NF-κB activity of nonalcoholic steatohepatitis (NASH) in rats. Methods Rats fed with a standard diet for one week were randomly divided into four groups: the control group ( n = 10), the 12-week-model group( n = 10), the 16-week-model group( n = 10) and the PTX treatment group( n = 10). Two model groups and the PTX treatment group were fed with a high-fat diet and the control group with a standard diet. After 12 week, the 12-week-model group were sacrificed and the treatment group were given PTX [ 16mg/( kg· d)] by intragastric administration. Then all the remaining rats were sacrificed at the end of the 16th week. The expressions of NF-κB and inhibitor κB-α(IκB-α) proteins in livers were analyzed by immunohistochemistry. The expression of NF-κBp65 protein was determined by Western blotting. Results The expression of NF-κBp65 increased significantly in the model groups and the PTX treatment group (vs the control group, P 〈 0.05) but decreased in the PTX treatment group (vs the model groups); the expression of IκB markedly decreased in the model groups and the PTX treatment group (vs the control group, P 〈 0.05) and increased in the PTX treatment group (vs the model groups, P 〈 0.05). Conclusion PTX can inhibit the degradation of IκB protein in rat livers and decrease the activity of NF-κB.
出处 《解剖学报》 CAS CSCD 北大核心 2008年第3期335-339,共5页 Acta Anatomica Sinica
基金 北京市重点实验室开放基金资助项目(ZK2005025) 北京市教育委员会科技发展计划资助项目(KM200710025003)
关键词 己酮可可碱 非酒精性脂肪性肝炎 核因子-ΚB κB抑制蛋白 免疫组织化学 免疫印迹法 大鼠 Pentoxifylline NASH NF-κB IκB Immunohistochemistry Western blotting Rat
  • 相关文献

参考文献13

  • 1Oliverjames.非酒精性脂肪性肝炎[J].国际内科双语杂志(中英文),2003,3(2):85-86. 被引量:3
  • 2Satapathy SK, Garg S, Chauhan R, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifilline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis[J]. Am J Gastroenteral, 2004, 99(10):1946-1952.
  • 3Akriviadis E, Botla R, Briggs W, et al. Pentoxifynine improves short- term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial[ J ]. Gastroenterol, 2000, 119 (6) : 1637-1648
  • 4钱燕,范建高,郑晓英,李锋,陆元善.己酮可可碱对高脂饮食大鼠脂肪性肝炎并肝纤维化的干预作用[J].肝脏,2005,10(2):136-137. 被引量:9
  • 5Pena AD, Leclercq I, Field J, et al. NF-kB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis [ J ]. Gastroenterology, 2005,129 (5) : 1663 - 1674.
  • 6Lopez-Franco O, Hernandez-Vargas P, Ortiz-Munoz G, et al. The NF- kB inhibitor parthenolide modulates the inflammatory responses in experimental atherosclerosis [ J ]. Atherosclerosis Supplements, 2005,6 (1):41.
  • 7Koppe SWP, Sahai A, Malladi P, et al. Pentoxifynine attenuates steatohepatitis induced by the methionine choline deficient diet[J]. J Hepatol, 2004, 41(4) :592-598.
  • 8Ji Q, Zhang LD, Jia HB, et al. Pentoxifylline inhibits endotoxin- induced NF-kappa B activation and associated production of proinflammatory cytokines[J]. Ann Clin Lab Sci, 2004,34 (4): 427-436.
  • 9Sanjay K, Grag S, Sakhuja P, et al. Pentoxifylline as a novel therapy for nonalcoholic steatohepatitis : a pilot study [ J ]. Gastroenterology, 2003, 124(4) : A758.
  • 10张莉,贾继东,张华,李宝红,孙海梅,曾晓蓓,张立新,王丹,安威.己酮可可碱治疗非乙醇性脂肪性肝炎的实验研究[J].首都医科大学学报,2006,27(3):332-336. 被引量:4

二级参考文献33

  • 1陈世清,刘杞,孙航,张桂灵,石小枫.脂肪肝胰岛素抵抗大鼠模型的建立[J].中华肝脏病杂志,2005,13(2):105-108. 被引量:46
  • 2王红梅,刘亚华,张建龙,孙湛.大鼠肝缺血/再灌注损伤时心肌组织能量代谢的变化[J].新疆医科大学学报,2005,28(4):350-352. 被引量:8
  • 3钱燕,范建高,郑晓英,李锋,陆元善.己酮可可碱对高脂饮食大鼠脂肪性肝炎并肝纤维化的干预作用[J].肝脏,2005,10(2):136-137. 被引量:9
  • 4Raetsch C, Jia JD, Boigk G, et al. Pentoxifylline down regulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut,2002,50: 241-247.
  • 5Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebocontrolled trial. Gastroenterology, 2000,119:1637-1648.
  • 6Sanjay K, Grag S, Sakhuja P, et al. Pentoxyfylline as a novel therapy for nonalcoholic steatohepatitis: a pilot study. Gastroenterology, 2003, 124:A758.
  • 7Vial P, Riquelme A, Pizarro M, et al. Pentoxifyline does not prevent early profibrogenic events in a rat model of nonalcoholic steatohepatitis.Gastroenterology, 2003, 124: A757.
  • 8Pessayre D,Mansouri A,Fromenty B.Non-alcoholic steatosis and steatohepatitis.V.Mitochondria dysfunction in steatohapatitis[J].Am J Physiol Gastroint Liver Physiol,2002,282:G193-199.
  • 9Kapiowitz N.Biochemical and cellular mechanisms of toxic liver injury[J].Semin Liver Dis,2002,22:137-144.
  • 10Crespo J,Cayon A,Fernandez-Gil P,et al.Gene expression of tumer necrosis factor a and TNF-receptors,p55 and p75,in non-alcoholic steatohepatitis patients[J].Hepatology,2001,34:1158-1163.

共引文献26

同被引文献29

  • 1张莉,贾继东,张华,李宝红,孙海梅,曾晓蓓,张立新,王丹,安威.己酮可可碱治疗非乙醇性脂肪性肝炎的实验研究[J].首都医科大学学报,2006,27(3):332-336. 被引量:4
  • 2Knodell RG,Ishak KG,Black WC,et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology,1981,1(5):431-435.
  • 3Oliver J.Nonalcoholic steatohepatitis[J].Bilingual Journal of Medicine International,2003,3(2):85-86/30-31.
  • 4Herbert T,Anna M.Cytokines in alcoholic and nonalcoholic steatohepatitis[J].N Engl Med,2000,343(20):1467-1476.
  • 5Manco M,Marcellini M,Giannone G,et al.Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease[J].Am J Clin Pathol,2007,127(6):954-960.
  • 6Kugelmas M,Hill DB,Vivian B,et al.Cytokines and NASH:A pilot study of the effects of lifestyle modification and vitamin E[J].Hepatology,2003,38(2):413-419.
  • 7Wigg AJ,Roberts-Thomson IC,Dymock RB,et al.The role of small intestinal bacterial overgrowth,intestinal permeability,endotoxaemia,and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis[J].Gut,2001,48(2):206-211.
  • 8Ribeiro PS,Cortez-Pinto H,Sola S,et al.Hepatocyte apoptosis,expression of death receptors,and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients[J].Am J Gastroenterol,2004,99(9):1708-1717.
  • 9Pena AD,Leclercq I,Field J,et al.NF-κB activation,rather than TNF,mediates hepatic inflammation in a murine dietary model of steatohepatitis[J].Gastroenterology,2005,129(5):1663-1674.
  • 10Duman DG,Ozdemir F,Birben E,et al.Effects of pentoxifylline on TNF-alph'a production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis[J].Gastroenterology,2006,130(4):A828.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部